Lutetium Lu 177-dotatate
Lutetium Lu 177-dotatate | |
---|---|
Term | Lutetium Lu 177-dotatate |
Short definition | Lutetium Lu 177-dotatate (loo-TEE-shee-er. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Lutetium Lu 177-dotatate - (pronounced) (loo-TEE-shee-er. . . DOH-tuh-tayt) A radioactive drug used to treat adults with gastroenteropancreatic neuroendocrine tumors that are somatostatin receptor positive. It is also being studied in the treatment of other types of cancer. Lutetium Lu 177 dotatate binds to a protein called the somatostatin receptor found on some neuroendocrine tumor cells. Lutetium Lu 177 dotatate builds up in these cells and emits radiation that can kill them. It's a type of radioconjugate and a type of somatostatin analog. Also called Lutathera
External links
- Medical encyclopedia article on Lutetium Lu 177-dotatate
- Wikipedia's article - Lutetium Lu 177-dotatate
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski